SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: t36 who wrote (4303)1/4/1998 8:08:00 PM
From: Tunica Albuginea  Read Replies (1) | Respond to of 23519
 
Sue, if I could tell you were Vivus will go short term, I would be working full time at Merrill-Lynch, hopefully at a greatly increased salary. Unfortunately gg that is not the case. I will not tell anybody what to buy because of market volatility/unpredictability( although I
have been desperately for the last 1 month trying to talk some hospital nurses that have no savings, to start putting some money in the stock maeket, and buy Intel Warrants at 50- or the stock; no luck so far. ). Anything is possible. I don't know - nobody knows - all the inns and outs of this stock or any stock. Th e stock may go to 8 as somebody suggested recently, or to 16. However, I do think that 1 year from now Vivus has an excellent chance of being over 30. I f you buy it at 10, then in 1 year you 'll have a 300% return, and you'll have beaten 99% of all money managers, for the next two years at least
even if you didn't make any other trade. GG . Good luck.

TA